Ratings by Needham (Chad Messer)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2026 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2026 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 12/20/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 11/8/2024 | NextCure Inc. | NXTC | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2023 | Gamida Cell Ltd. | GMDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | NextCure Inc. | NXTC | Maintain | Buy (Buy) |
|
Details | ||
| 4/26/2022 | Gamida Cell Ltd. | GMDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2022 | NextCure Inc. | NXTC | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2022 | Seagen | SGEN | Maintain | Buy (Buy) |
|
Details | ||
| 1/5/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2021 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | NextCure Inc. | NXTC | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2021 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | Esperion Therapeutics | ESPR | Maintain | (N/A) |
|
Details | ||
| 7/27/2021 | Celcuity Inc | CELC | New Coverage | Buy (N/A) |
20.68 (93.24) |
350.87% | Details | |
| 7/19/2021 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2021 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2021 | Avidity Biosciences | RNA | New Coverage | Buy (N/A) |
26.09 (49.15) |
88.39% | Details | |
| 6/7/2021 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | AUTL | AUTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2021 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2021 | Mereo BipPharma Group | MREO | New Coverage | Buy (N/A) |
3.38 (0.31) |
-90.83% | Details | |
| 3/16/2021 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2021 | Athenex | ATNX | Downgrade | Hold (Buy) |
12.10 (0.20) |
-98.35% | Details | |
| 2/25/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2021 | Esperion Therapeutics | ESPR | Maintain | (N/A) |
|
Details | ||
| 9/30/2020 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2020 | Nurix | NRIX | New Coverage | Buy (N/A) |
27.00 (26.93) |
-0.26% | Details | |
| 7/30/2020 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Athersys | ATHX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2020 | Akebia Therapeutics | AKBA | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2020 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Esperion Therapeutics | ESPR | Maintain | (N/A) |
|
Details | ||
| 12/19/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2019 | ArQule | ARQL | Downgrade | Hold (Buy) |
9.66 (20.00) |
107.04% | Details | |
| 12/5/2019 | NextCure Inc. | NXTC | New Coverage | Buy (N/A) |
51.01 (6.65) |
-86.96% | Details | |
| 11/8/2019 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2019 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | ArQule | ARQL | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | Seattle Genetics | SGEN | Maintain | Buy (Buy) |
|
Details | ||
| 10/24/2019 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2019 | Akcea Therapeutics, Inc. | AKCA | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2019 | AUTL | AUTL | New Coverage | Buy (N/A) |
13.09 (2.29) |
-82.51% | Details | |
| 8/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2019 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2019 | Gamida Cell Ltd. | GMDA | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2019 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2019 | ArQule | ARQL | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2019 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2019 | ArQule | ARQL | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2019 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2019 | Geron Corporation | GERN | Upgrade | Buy (Hold) |
1.82 (1.53) |
-15.93% | Details | |
| 3/25/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2019 | Aerpio Pharmaceuticals | ARPO | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | Athersys | ATHX | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2019 | Progenics Pharmaceuticals | PGNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2019 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2019 | ArQule | ARQL | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2019 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2019 | Vericel Corporation | VCEL | Downgrade | Hold (Buy) |
18.92 (44.26) |
133.93% | Details | |
| 2/13/2019 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2019 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2019 | Selecta Biosciences | SELB | Maintain | Buy (Buy) |
|
Details | ||
| 11/26/2018 | Gamida Cell Ltd. | GMDA | New Coverage | Buy (N/A) |
11.47 (0.03) |
-99.74% | Details | |
| 11/13/2018 | PhaseBio Pharmaceuticals Inc. | PHAS | New Coverage | Buy (N/A) |
5.01 (0.07) |
-98.6% | Details | |
| 11/8/2018 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2018 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2018 | Aevi | GNMX | Maintain | Buy (N/A) |
|
Details | ||
| 10/9/2018 | Akcea Therapeutics, Inc. | AKCA | Maintain | Buy (Buy) |
|
Details | ||
| 9/21/2018 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2018 | Akcea Therapeutics, Inc. | AKCA | New Coverage | Buy (N/A) |
24.16 (18.17) |
-24.79% | Details | |
| 9/17/2018 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2018 | Progenics Pharmaceuticals | PGNX | Downgrade | Buy () |
7.30 (4.10) |
-43.84% | Details | |
| 9/6/2018 | Histogenics Corp. | HSGX | Maintain | Buy (N/A) |
|
Details |
